Position in GILD
as of Jun 30, 2026
· filed Jul 6, 2026
Position Value
$5,183,224
+$828,051 QoQ
Shares Held
41,026
+31.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.91%
of 13F equity value
Holder Rank
#573
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Trilogy Capital Inc. holds $25,279,882 across 7 Drug Manufacturers - General names. GILD ranks #3 (20.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,952 | $7,139,007 | |
| 2 | ABBV |
AbbVie Inc.
|
23,338 | $5,872,774 | |
| 3 | GILD |
Gilead Sciences, Inc.
This page
|
41,026 | $5,183,224 | |
| 4 | MRK |
Merck & Co., Inc.
|
40,029 | $5,143,726 | |
| 5 | JNJ |
Johnson & Johnson
|
5,109 | $1,297,532 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
5,935 | $341,974 | |
| 7 | AMGN |
Amgen Inc
|
833 | $301,645 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,183,224 | 41,026 | Shares | Sole | 2026-07-06 | |
| 2026-03-31 | $4,355,173 | 31,249 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $3,645,746 | 29,703 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $3,052,389 | 27,499 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $3,054,135 | 27,547 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $3,725,326 | 33,247 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $3,446,047 | 37,307 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $3,443,476 | 41,072 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $2,834,073 | 41,307 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $2,791,997 | 38,116 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $398,083 | 4,914 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $402,577 | 5,372 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $446,312 | 5,791 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $418,915 | 5,049 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $2,434,105 | 28,353 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,909,613 | 30,955 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $1,688,834 | 27,323 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $1,262,955 | 21,244 | Shares | Sole | 2022-04-08 | |
| 2021-12-31 | $1,231,465 | 16,960 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $1,131,779 | 16,203 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $1,114,430 | 16,184 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $637,639 | 9,866 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $531,622 | 9,125 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $573,702 | 9,079 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $726,236 | 9,439 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $595,538 | 7,966 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||